
Andreea Alexandra Milca
Age 36 · Female
""I am deeply grateful to CancerFax for guiding me to life-saving advanced treatment options like Gendicine and TT Vaccine.""
my Story
My name is Andrea Alexandra Milca.
What may appear to be just a name carries within it a lifetime of battles, resilience, and an unwavering belief that knowledge can save lives.
At the age of 23, my life changed forever. I was diagnosed with triple-negative breast cancer—an aggressive form of the disease that arrives without warning and leaves little room for hesitation. That diagnosis was only the beginning. In the years that followed, cancer returned in different forms: osteosarcoma and other tumors, each time testing not only my body, but my spirit.
Every diagnosis felt like a heavy blow. Fear, uncertainty, and physical pain became part of my daily reality. Yet, with each challenge, I made a conscious choice: to fight, to understand, and to move forward.
A turning point came when I discovered that I carry a TP53 gene mutation, associated with Li-Fraumeni syndrome—a rare hereditary condition that significantly increases the risk of developing multiple cancers at a young age. This knowledge explained my medical journey, but more importantly, it revealed a truth that too many patients discover too late: genetics matter.
Understanding my genetic vulnerability transformed my perspective. It showed me that prevention, early detection, and genetic testing are not optional luxuries—they are life-saving tools. Had this information been available earlier, my path might have been different. But instead of allowing regret to define me, I chose to let purpose guide me.
From Survival to Responsibility
Surviving cancer multiple times changes how you see the world. It sharpens your awareness of how fragile life is—and how powerful informed action can be. I realized that my experience was not meant to end with survival alone. It carried a responsibility: to help others navigate their own journeys with more clarity, support, and hope.
This conviction led to the creation of Sanatatea Viitorului (Health of the Future)—an association born from lived experience, not theory. Its mission is simple yet vital:
- to promote genetic awareness and testing,
- to advocate for early diagnosis and preventive care,
- to support patients and families facing uncertainty,
- and to contribute to a future where fewer lives are lost due to late detection.
A Future Built on Knowledge and Hope
Sanatatea Viitorului exists because I believe no one should walk this path alone, uninformed, or unheard. Every patient deserves access to knowledge, to modern medical tools, and to hope grounded in science.
My journey has been marked by illness—but also by courage, learning, and transformation. Today, I stand not only as a survivor, but as an advocate for change. Because when we understand our risks, we gain power. And when we act early, we give ourselves a future.
““Knowing my genetic risk didn’t take away my fear; it gave me clarity. And clarity can save lives.””
Why the Family Contacted CancerFax
Andreea needed access to advanced therapies not available in Romania — including Gendicine, a gene therapy approved in China, and immunotherapy options not yet accessible in her home country. She also needed support in understanding how her genetic profile shaped her treatment options.
A TP53 mutation changes the risk profile and treatment landscape significantly. Specialist oncogenetics review was needed to understand the implications and identify appropriate therapies.
Gendicine and therapeutic vaccines are available in China and represent options not accessible in Romania. Understanding whether they were appropriate for Andreea's profile required specialist matching.
Coordinating international treatment access — including understanding what is available, how to apply, and how to prepare the case file — required navigational support that Andreea could not build alone.
"I am deeply grateful to CancerFax for guiding me to life-saving advanced treatment options like Gendicine and TT Vaccine."— Andreea Alexandra Milca, Patient & Advocate
How CancerFax Helped
CancerFax helped Andreea navigate her complex, multi-diagnosis journey by reviewing her case, identifying advanced treatment options relevant to her genetic profile, and coordinating access to therapies not available in Romania.
Andreea's multi-diagnosis history — spanning breast cancer, osteosarcoma, and subsequent recurrences — was organised and structured for specialist review.
Her TP53 mutation and Li-Fraumeni syndrome were factored into the assessment of which treatment options and specialists were relevant to her specific situation.
CancerFax supported access to Gendicine (gene therapy) and the TT Vaccine (therapeutic immunotherapy) — treatments not available in Romania but accessible through specialist centres abroad.
Given the complexity and duration of Andreea's journey, ongoing coordination and communication support was provided across multiple stages of her treatment.
Andreea's Treatment Journey
From diagnosis at 23 to advocacy — a multi-year journey across cancer types and borders.
Andreea was diagnosed with TNBC at 23 — an aggressive form of breast cancer that requires immediate, intensive treatment. It was the beginning of a long and complex medical journey.
In subsequent years, cancer returned in different forms including osteosarcoma. Each relapse required new evaluation, new treatment decisions, and renewed resilience.
Genetic testing identified a TP53 mutation associated with Li-Fraumeni syndrome — a hereditary condition that substantially increases lifetime cancer risk. This changed the framework for understanding and managing her ongoing care.
Andreea connected with CancerFax to explore advanced treatment options not available in Romania, including gene therapy and immunotherapy approaches relevant to her genetic profile.
Andreea received Gendicine — a gene therapy approved in China — and the TT Vaccine, a therapeutic immunotherapy approach. These represented advanced options beyond what was accessible locally.
Drawing on her experience, Andreea founded Sanatatea Viitorului (Health of the Future) — an association built on the belief that knowledge, early genetic testing, and informed action can save lives for others facing similar risks.
Every patient's treatment plan is individual. The pathway above describes this specific case — not a blueprint for others. Suitability for each treatment is determined by the treating clinical team based on each patient's individual clinical situation.
Where Andreea Alexandra Is Today
Andreea has survived multiple cancer diagnoses across more than a decade. Today, she stands not only as a patient who navigated one of the most complex hereditary cancer profiles possible — but as a voice for change in how cancer risk, genetic testing, and advanced therapy access are understood and communicated.
She founded Sanatatea Viitorului (Health of the Future) — an association whose mission is to ensure that no patient walks the cancer path alone, uninformed, or without access to the knowledge that could change their outcome.
Her message is clear: "When we understand our risks, we gain power. And when we act early, we give ourselves a future."
“"I am deeply grateful to CancerFax for guiding me to life-saving advanced treatment options like Gendicine and TT Vaccine."”— Andreea Alexandra Milca, Patient & Advocate
Now living without the burden of regular transfusions, Chen Yan is embracing new experiences: continuing his university studies, engaging in community awareness, and mentoring others living with haemoglobin disorders. His story is not just about survival, it’s about thriving.
What Other Families Can Learn
Andreea's journey carries important lessons — particularly for young patients, families with hereditary cancer risk, and anyone who has been told that advanced treatment options do not exist.
Identifying a TP53 mutation or Li-Fraumeni syndrome changes the treatment and surveillance framework entirely. For patients with multiple cancers or early-onset disease, genetic testing should be part of the standard diagnostic process.
Gendicine and therapeutic vaccines are approved and in clinical use in China, but not yet accessible in most European countries. Knowing these options exist — and understanding eligibility — requires specialist knowledge.
The earlier a patient reaches a specialist oncogeneticist and a centre experienced in hereditary cancer syndromes, the broader the treatment options available.
Andreea's decision to found Sanatatea Viitorului shows how lived experience can be transformed into guidance for others who follow the same path.
Related on CancerFax
Frequently Asked Questions
This patient story reflects an individual treatment journey. Outcomes vary from patient to patient. The information on this page should not be taken as medical advice or a guarantee of similar results. Treatment suitability depends on diagnosis, disease status, prior therapy, molecular findings, overall health, and specialist medical evaluation. Names and identifying details may be modified to protect patient privacy. All clinical decisions must be made in consultation with a qualified, licensed physician with access to the patient's complete medical information.
Need Help Understanding the Next Step?
If you or a loved one is facing a complex cancer diagnosis, relapse, or limited treatment options, CancerFax can help you organise the case, explore relevant hospitals and doctors, and understand whether advanced treatment or clinical trial pathways may be appropriate.
© CancerFax · Patient navigation and coordination platform. CancerFax is not a medical institution and does not provide medical treatment. All clinical care is provided by independent licensed physicians and hospitals. Patient names and identifying details are modified or anonymised where required to protect privacy. Story shared with documented family consent.